MANUELA ASZTALOS, M.D.
Dermatology Physician in PARADISE VALLEY, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MANUELA ASZTALOS, M.D. reported a CMS MIPS final score of 76.4624/100 — below the 83.1 national average — and filed 565 Medicare Part D claims in 2023.
- 76.4624/100
- MIPS score · -7 vs avg
- 565
- Part D claims, 2023
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MANUELA ASZTALOS, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
76 21st percentile higher than 21% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MANUELA ASZTALOS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MANUELA ASZTALOS, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Arizona
How Dermatology Physician compares to other specialties among Arizona providers
Dermatology Physician share within Arizona
Dermatology Physician is one of the more visible NUCC categories in Arizona
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MANUELA ASZTALOS, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 76.4624/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) — 76.4624/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Dermatology Physician US NPIs
76.4624/100 MIPS final score — 6.6 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician. Quality dim: 59.3862.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MANUELA ASZTALOS, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 5206 N SCOTTSDALE RD, PARADISE VALLEY, AZ, 85253, with a listed phone of (480) 771-1122. NPI 1609162049 was issued on 06/23/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ASZTALOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 565 prescription claims written by this provider, covering 282 Medicare beneficiaries and totaling roughly $96K in drug spend, split 5% brand-name and 95% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.4624/100 for the 2023 performance year (Quality 59.3862), compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1609162049 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/23/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MANUELA ASZTALOS, M.D.'s current license status, disciplinary history, and board certifications with the Arizona Medical Board in Arizona before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where MANUELA ASZTALOS, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MANUELA ASZTALOS, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.9K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
5% brand-name claims vs 95% generic, on 565 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 598
- Total Day Supply
- 13,793
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $81K
- Generic Drug Cost
- $14K
- Antibiotic Claims
- 56
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.04
- Gender Split
- 64% female / 36% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MANUELA ASZTALOS, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ketoconazole
Ketoconazole
96 claims
- Triamcinolone Acet…
Triamcinolone Acetonide
93 claims
- Clobetasol Propion…
Clobetasol Propionate
86 claims
- Hydrocortisone
Hydrocortisone
43 claims
- Doxycycline Hyclate 33
Doxycycline Hyclate
33 claims
- Valacyclovir 23
Valacyclovir
23 claims
- Metronidazole 20
Metronidazole
20 claims
- Mupirocin 18
Mupirocin
18 claims
| Drug | Claims |
|---|---|
| Ketoconazole | 96 |
| Triamcinolone Acetonide | 93 |
| Clobetasol Propionate | 86 |
| Hydrocortisone | 43 |
| Doxycycline Hyclate | 33 |
| Valacyclovir Valacyclovir Hcl | 23 |
| Metronidazole | 20 |
| Mupirocin | 18 |
| Methylprednisolone | 15 |
| Clindamycin Phosphate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How MANUELA ASZTALOS, M.D. fits within the Dermatology Physician landscape nationally.
MANUELA ASZTALOS, M.D.'s 565 claims are below the specialty average of 729.
Nearby Dermatology Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as ASZTALOS.
Compare Dermatology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arizona
Frequently Asked Questions
What is MANUELA ASZTALOS, M.D.'s specialty? ▼
How much does MANUELA ASZTALOS, M.D. prescribe under Medicare Part D? ▼
What is MANUELA ASZTALOS, M.D.'s Medicare quality score? ▼
Where is MANUELA ASZTALOS, M.D. located? ▼
What is MANUELA ASZTALOS, M.D.'s NPI number? ▼
Does MANUELA ASZTALOS, M.D. prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does MANUELA ASZTALOS, M.D. prescribe most often? ▼
Does MANUELA ASZTALOS, M.D. accept Medicare? ▼
How can I verify MANUELA ASZTALOS, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology